Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:13 PM
Ignite Modification Date:
2025-12-24 @ 5:13 PM
NCT ID:
NCT06490250
Eligibility Criteria:
Inclusion Criteria:
* Myocardial thickness in any region of the left ventricle is 15 mm or more on echocardiography or cardiac MRI
* Clinically and hemodynamically stable (patients with NYHA Class I and II)
* Patients over 18 years of age
* Patients who provide informed consent
Exclusion Criteria:
* Acute decompensated heart failure
* Decreased ejection fraction (\<40%)
* Unstable angina pectoris
* Significant coronary artery disease (CAD)
* Severe renal dysfunction (estimated glomerular filtration rate \<30 mL/min/m²)
* Uncontrolled hypertension (despite medication)
* Severe valve disease (moderate-severe aortic stenosis, advanced mitral regurgitation)
* Severe neurological disorders causing autonomic dysfunction
* Cognitive impairment that prevents communication
* Recent fractures, osteoporosis, presence of tumors, pregnancy, or back and spine problems
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06490250
Study Brief:
Protocol Section:
NCT06490250